Molecular Diagnostics
News on lab-developed tests and emerging diagnostic technologies.
HER2 Treatments See New Milestones in Colorectal Cancer, With Liquid Biopsy Identifying Responders
Premium
New data from a Japanese Phase II study have solidified a path forward for pertuzumab plus trastuzumab in HER2-positive colorectal cancer patients.
Centogene Reports 17 Percent Drop in Q3 Revenues, Closing Down COVID Testing Business
Given its dwindling cash position, the firm will phase out its COVID-19 testing business and streamline its footprint, resulting in up to €15 million in cost savings per year.
Local Cancer Genomic Profiling Options Grow, Though Central Labs Will Likely Keep Major Role
Premium
As economic and practical challenges of next-gen sequencing have eased in recent years, more groups are bringing comprehensive cancer genomic testing in house.
StageZero Raising C$4.2M in Private Placement of Stocks, Warrants
The proceeds will help the company accelerate its global growth strategy and further commercialize key products.
NGeneBio Gets CE-IVD Mark for HLA Typing Assay
The South Korean company said it now intends to begin expanding into international markets for HLA testing, beginning with Europe.